Genomic Solutions Says Q3 Revenue Outlook Dims, Blames Attacks | GenomeWeb

NEW YORK, Sept. 28 - Genomic Solutions said on Friday that its third-quarter revenue might be half of what it originally expected, blaming shrinking orders and economic uncertainty in the wake of the attacks on the World Trade Center and the Pentagon on Sept. 11. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.